Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ P5Y:c@u2
3?
F*|E_
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© K]{Y >w
A~_*vcz
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© [=[>1<L>
$^F
L*w
1.Co-stimulators (or co-stimulating molecules) YL_M=h>P
C:+-T+m[
2.NK-kB rz%8Vigb
038|>l-9[
3.Immunoglobulin superfamily 6;WfsG5
KTr7z^
4.antigen-presenting cell (APC) N8!V%i?
cI~uI'
5.death domain %~eIx=s
{O ]^8#v^
6.CCR and CXCR '
U]\]Wp
$#VE C0
7.Lectin (or mitogen) a<c]N:1
n7g}u
8.Clusters of differentiation, CD) pZo:\n5o
BG>fLp
9.B7 family Ass :
u
sj:I`>
10.Cytotoxic T lymphocyte, CTL) GRM:o)4;#
T_\Nvzb}
11.IL-15 and IL-15 receptor (IL-15R) N|JML
ENZjRf4
12.MHC restriction uX82q.u_y
BK$cN>J
13.Affinity-chromatography f4%Z~3P
3j
St&+
14.Cyctosprin A, CsA b|SDg%e
C K#^`w
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) {KQ-QKxxS
{}.M(nPtv;
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© O0Z!*Hy
1zNh&
"
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 6d7E@}<
!uZ)0R
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ GZefeBi
a/wg%cWG_
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ NL^;C
3u
|WkWZZ^
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 1tZ7%0R\g]
XE#a#
ÃâÒßѧרҵ£º 8}M-b6RV
/1y\EEc
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ |*fi!nvk@
.8%&K0
Ïû»¯ÄÚ¿Æ£º pyw]ydB
]
/"!J6(e
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ Yt!o
Hn
/4I9Elr
ѪҺ²¡Ñ§×¨Òµ£º #
x+7-hi
T^ )\
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿